Latest news

Bioservo Technologies AB publishes prospectus (regulatory information)

Bulletin from Extraordinary General Meeting in Bioservo (regulatory information)

World’s first soft robotic muscle strengthening system. Developed in collaboration with leading Fortune 500 companies

Menu

12 Aug, 2022

Bioservo signs an agreement for the sale of Carbonhand® with Rehasys in Switzerland

Bioservo Technologies AB has signed a distribution agreement with Rehabilitations Systeme AG for the sale of Carbonhand® in Switzerland. The agreement provides access to a new lucrative market and is part of a strong investment in Life Science.

Rehasys is one of Switzerland's leading suppliers of technical and medical aids and rehabilitation equipment for people with limited mobility. The company was founded in 1926 and today has a large customer base and caters to health institutions such as rehabilitation clinics, hospitals, nursing homes, doctors' surgeries and orthopedic and medical stores as well as private individuals. They proactively work to introduce new technology to ensure a comprehensive offering to their customers.

The agreement means that Rehasys will work actively with clinics and other healthcare providers to introduce our latest product, Carbonhand 2.0, in Switzerland, a country that has a well-developed system for prescribing technical aids.

"Switzerland has a well-developed and generous system for prescribing assistive devices. Through Rehasys' market position and broad network of contacts among both rehabilitation clinics and other healthcare facilities, we see great opportunities for a successful introduction of Carbonhand in an exciting market." says Petter Bäckgren, CEO at Bioservo and continues, "Soon we will launch a completely new version of Carbonhand, a strength-enhancing glove for people with reduced hand function. An aid that, according to preliminary data from an ongoing study*, greatly improves grip strength and hand function. Rehasys are ready and eager to present Carbonhand to their customers as soon as the product is available.”


For further information please contact:
Petter Bäckgren, CEO
petter.backgren@bioservo.com
+46 8 21 17 10

Mikael Wester, Marketing Director
Mikael.wester@bioservo.com
+46 8 21 17 10


About Bioservo Technologies
Bioservo Technologies AB (publ) is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy, and efficient. The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health for workers and to improve quality of life for people with reduced muscle strength. Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.

FNCA Sweden AB, +46(0)8-52800399, info@fnca.se is the company’s Certified Adviser on Nasdaq First North

For more information, please visit www.bioservo.com


*Kottink AIR, Nikamp CDM, Buurke JH, Bos F, van der Sluis CK, van den Broek M, Onneweer B, Stolwijk-Swüste JM, Brink SM, Rietman JS, Prange-Lasonder GB. Carbonhand during ADL. IFSSH, IFSHT & FESSH Combined Congress. June 6-10 2022. ExCeL, London. The clinical trial has been conducted within the framework of the iHand project. The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 801945